Top Markets
#1 MowCat MowCat +48.45%
#2 Bermuda Shorts Bermuda Shorts +31.49%
#3 Biconomy Biconomy +22.77%
#4 Velvet Velvet +21.04%
#5 Derive Derive +17.92%
#6 MarsCoin MarsCoin +17.75%
#7 Quack AI Quack AI +17.33%
#8 Audiera Audiera +14.23%
#9 Perle Perle +14.15%
#10 aPriori aPriori +13.82%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Medigene AG Medigene AG

Medigene AG

MDG1
Rank in Stocks #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Share Price
$0.14942078
Last synced: 2025-05-15
Market Cap
$3.86M
Change (1 day)
0.10%
Change (1 year)
0.00%
Country
DE
Trade Medigene AG (MDG1)

Category

Healthcare
Number of shares outstanding for Medigene AG (MDG1)
Number of shares outstanding as of June 2024: 12.93M
According to Medigene AG latest financial reports and stock price the company's current number of shares outstanding is 12.93M. At the end of December 2022 the company had 12.93M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Medigene AG (MDG1) from 2004 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 12.93M 5.30%
2023 12.28M -5.04%
2022 12.93M 0.00%
2021 12.93M 0.00%
2020 12.93M 0.01%
2019 12.93M -48.12%
2018 24.93M 10.08%
2017 22.64M 7.76%
2016 21.01M 25.00%
2015 16.81M 37.65%
2014 12.21M 27.07%
2013 9.61M 3.65%
2012 9.27M 89.92%
2011 4.88M 1.42%
2010 4.81M 6.81%
2009 4.51M 0.66%
2008 4.48M 7.82%
2007 4.15M 40.74%
2006 2.95M 20.75%
2005 2.44M 32.61%
2004 1.84M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 1,863.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 380.84%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE